Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model

Journal of Cerebral Blood Flow and Metabolism

Volumn 27, Issue 7, 2007, Pages 1387-1396

  Zhang, Ming ^a   Martin, Billy R ^b   Adler, Martin W ^a   Razdan, Raj K ^c   Jallo, Jack I ^d   Tuma, Ronald F ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ORGANIX INC   (United States)

^d TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Cannabinoid receptors; CB2 agonists; Leukocytes; Stroke

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; ENDOTHELIUM; LEUKOCYTE; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION; VENULE;

ANIMALS; BRAIN; CELL ADHESION; CEREBRAL INFARCTION; ENDOTHELIUM, VASCULAR; LEUKOCYTE ROLLING; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; RECEPTOR, CANNABINOID, CB2; REPERFUSION INJURY;

EID: 34250717998     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600447     Document Type: Article

References (40)

1. Belayev L, Busto R, Zhao W, Fernandez G, Ginsberg MD (1999) Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res 833:181-90
2. Berdyshev EV (2000) Cannabinoid receptors and the regulation of immune response. Chem Phys Lipids 108:169-90
3. Connolly Jr ES, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, Stern DM, Solomon RA, Gutierrez-Ramos JC, Pinsky DJ (1996) Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 97:209-16
4. Croxford JL (2003) Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 17:179-202
5. Danton GH, Dietrich WD (2003) Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62:127-36
6. Grundy RI (2002) The therapeutic potential of the cannabinoids in neuroprotection. Expert Opin Invest Drugs 11:1365-74
7. Grundy RI, Rabuffetti M, Beltramo M (2001) Cannabinoids and neuroprotection. Mol Neurobiol 24:29-51
8. Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, Brinker G, Hossmann KA (1998) A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18:367-75
9. Hayakawa K, Mishima K, Abe K, Hasebe N, Takamatsu F, Yasuda H, Ikeda T, Inui K, Egashira N, Iwasaki K, Fujiwara M (2004) Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism. Neuro-Report 15:2381-5
10. Heinel LA, Rubin S, Rosenwasser RH, Vasthare US, Tuma RF (1994) Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res Bull 34:137-41
11. Iadecola C, Alexander M (2001) Cerebral ischemia and inflammation. Curr Opin Neurol 14:89-94
12. Jackson SJ, Diemel LT, Pryce G, Baker D (2005) Cannabinoids and neuroprotection in CNS inflammatory disease. J Neurol Sci 233:21-5
13. Kanemoto Y, Nakase H, Akita N, Sakaki T (2002) Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model. Neurosurgery 51:1034-41, discussion 1041-32
14. Kataoka H, Kim SW, Plesnila N (2004) Leukocyte-endothelium interactions during permanent focal cerebral ischemia in mice. J Cereb Blood Flow Metab 24:668-76
15. Kishimoto TK, Rothlein R (1994) Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv Pharmacol 25:117-69
16. Klein TW, Gabral G (2006) Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J Neuroimmune Pharmacol 1:50-64
17. Klein TW, Newton CA, Friedman H (2001) Cannabinoids and the immune system. Pain Res Manage 6:95-101
18. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara K, Yagita Y, Yanagihara T, Hori M, Matsumoto M (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31:1735-43
19. Maier CM, Hsieh L, Yu F, Bracci P, Chan PH (2004) Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia. Stroke 35:1169-74
20. Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95:437-45
21. Martin BR, Jefferson RG, Winckler R, Wiley JL, Thomas BF, Crocker PJ, Williams W, Razdan RK (2002) Assessment of structural commonality between tetrahydrocannabinol and anandamide. Eur J Pharmacol 435:35-42
22. Mishima K, Hayakawa K, Abe K, Ikeda T, Egashira N, Iwasaki K, Fujiwara M (2005) Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36:1077-82
23. Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ (2004) Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience 129:743-50
24. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19:2987-95
25. Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF (2004) Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult Scler 10:158-64
26. Nunez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonzalez S, Tolon RM, Romero J (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53:208-13
27. Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA (2002) Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci 22:9771-5
28. Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635-64
29. Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M (2005) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40:2-14
30. Saetzler RK, Jallo J, Lehr HA, Philips CM, Vasthare U, Arfors KE, Tuma RF (1997) Intravital fluorescence microscopy: impact of light-induced phototoxicity on adhesion of fluorescently labeled leukocytes. J Histochem Cytochem 45:505-13
31. Schilling M, Besselmann M, Muller M, Strecker JK, Ringelstein EB, Kiefer R (2005) Predominant phagocytic activity of resident microglia over hematogenous macrophages followingtransient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 196:290-7
32. Schwenkreis P, Tegenthoff M (2003) Therapeutic use of cannabinoids in neurology]. Schmerz 17:367-73
33. Sughrue ME, Mehra A, Connolly Jr ES, D'Ambrosio AL (2004) Anti-adhesion molecule strategies aspotential neuroprotective agents in cerebral ischemia: a critical review of the literature. Inflamm Res 53:497-508
34. Tsuchiya D, Hong S, Kayama T, Panter SS, Weinstein PR (2003) Effect of suture size and carotid clip application uponblood flow and infarct volume after permanent and temporary middle cerebral artery occlusion in mice. Brain Res 970:131-9
35. Vasthare US, Heinel LA, Rosenwasser RH, Tuma RF (1990) Leukocyte involvement in cerebral ischemia and reperfusion injury. Surg Neurol 33:261-5
36. Walter L, Stella N (2004) Cannabinoids and neuroinflammation. Br J Pharmacol 141:775-85
37. Weaver M, Leshley K, Sands H, Gritman KR, Legos JJ, Tuma RF (2002) LEX032, a novel recombinant serpin, protects the brain after transient focal ischemia. Microvasc Res 63:327-34
38. White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179:1-33
39. Wiley JL, Beletskaya ID, Ng EW, Dai Z, Crocker PJ, Mahadevan A, Razdan RK, Martin BR (2002) Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists. J Pharmacol Exp Ther 301:679-89
40. Wood PL (2003) Neuroinflammation: mechanisms and management. Totowa, NJ: Humana Press